The recent Federal Court of Australia decision of Boehringer Ingelheim Animal Health USA Inc v Zoetis Services LLC1 has (on one aspect) highlighted the ongoing attention given by the Federal Court of Australia upon the construction of the word “comprising” in the main claims of patents. The Court’s construction of the word “comprising” in the […]
Biotechnology Patent Update
The recent Australia Patent Office decision of Zoetis Services LLC v Boehringer Ingelheim Vetmedica GmbH [2024] APO 4 dated 8th February 2024 has (on one aspect) highlighted the challenge for clinical researchers and innovators when reporting interim clinical trial results by way of press releases. The Australian Patent Office held that the press release reporting […]